Equillium (EQ) News Today $0.50 -0.06 (-10.45%) Closing price 04:00 PM EasternExtended Trading$0.49 -0.01 (-1.45%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EQ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Equillium Shares Drop 12.4% After Unveiling Cryptocurrency Treasury StrategyAugust 4, 2025 | msn.comSpotlight On 3 Promising Penny Stocks With Over $20M Market CapAugust 4, 2025 | finance.yahoo.comEquillium stock falls after announcing cryptocurrency treasury strategyAugust 4, 2025 | au.investing.comEquillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve StrategyAugust 4, 2025 | businesswire.comInterleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsightJuly 11, 2025 | finance.yahoo.comEquillium, Inc. (EQ) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comEquillium expands equity incentive plan by 1.78 million sharesMay 24, 2025 | investing.comEquillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of ImmunologistsMay 6, 2025 | finance.yahoo.comEquillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504May 1, 2025 | finance.yahoo.comBlood Cancer Data Ignore Sex; Cancer Biosimilars Take Off; Mixed Prevention NewsApril 26, 2025 | msn.comEquillium says FDA declines Breakthrough Therapy designation for itolizumabApril 25, 2025 | markets.businessinsider.comLeerink says Equillium’s itolizumab news ‘disappointing but not surprising’April 25, 2025 | markets.businessinsider.comEquillium shares fall following FDA feedbackApril 24, 2025 | in.investing.comEquillium Announces Feedback from the U.S. Food and Drug AdministrationApril 24, 2025 | finance.yahoo.comEquillium downgraded to Market Perform from Outperform at LeerinkMarch 29, 2025 | markets.businessinsider.comEquillium reports Q4 EPS (16c) vs. (7c) last yearMarch 28, 2025 | markets.businessinsider.comEquillium reports EQUATOR study did not improve complete, overall response ratesMarch 28, 2025 | markets.businessinsider.comEquillium Full Year 2024 Earnings: Beats ExpectationsMarch 28, 2025 | finance.yahoo.comEquillium pushes for breakthrough status despite missing primary endpointMarch 27, 2025 | finance.yahoo.comPenny Stock Equillium Falls After Itolizumab Treatment Fails To Show Improvement In Response Rates In Graft Versus Host Disease PatientsMarch 27, 2025 | benzinga.comEquillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host DiseaseMarch 27, 2025 | businesswire.comEquillium reports positive Phase 2 ulcerative colitis study dataFebruary 6, 2025 | msn.comEquillium announces itolizumab study achieves secondary endpointFebruary 6, 2025 | markets.businessinsider.comEquillium stock rallies 26% on itolizumab study dataFebruary 6, 2025 | msn.comEquillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative ColitisFebruary 6, 2025 | finance.yahoo.comEquillium CFO Jason Keyes sells $6,500 in stockJanuary 24, 2025 | msn.comEquillium stock touches 52-week low at $0.52 amid market challengesJanuary 21, 2025 | msn.comUS Penny Stocks To Watch In January 2025January 2, 2025 | finance.yahoo.comEquillium Announces Board and Audit Committee ChangesDecember 13, 2024 | markets.businessinsider.comEquillium reports Q3 EPS 0c, consensus (26c)November 14, 2024 | markets.businessinsider.comEquillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical UpdatesNovember 13, 2024 | businesswire.comEquillium Announces Poster Presentation at the Society for Immunotherapy of CancerNovember 12, 2024 | finance.yahoo.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Equillium (EQ), Quest Diagnostics (DGX) and Alnylam Pharma (ALNY)November 5, 2024 | markets.businessinsider.comEquillium (EQ) Gets a Buy from Stifel NicolausNovember 5, 2024 | markets.businessinsider.comJones Trading Downgrades Equillium (EQ)November 1, 2024 | msn.comEquillium temporarily pausing EQUATOR enrollment to review clinical optionsNovember 1, 2024 | markets.businessinsider.comU.S. shares lower at close of trade; Dow Jones Industrial Average down 0.90%October 31, 2024 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.90%October 31, 2024 | msn.comEquillium says Ono not acquiring itolizumab, stock craters 36%October 31, 2024 | msn.comInvestors Await Key Inflation, Employment Data as US Futures Move Lower in Thursday's PremarketOctober 31, 2024 | msn.comEquillium Maintains Rights to Itolizumab Following Ono PartnershipOctober 31, 2024 | finance.yahoo.comEquillium, Inc. (NASDAQ:EQ) COO Sells $18,750.00 in StockOctober 31, 2024 | insidertrades.comEquillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of CancerOctober 7, 2024 | finance.yahoo.comEquillium (NASDAQ:EQ) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comPenny Tom Sells 38,806 Shares of Equillium, Inc. (NASDAQ:EQ) StockSeptember 18, 2024 | insidertrades.comEquillium collaborates with Vivtex for oral formulation of autoimmune therapySeptember 17, 2024 | msn.comEquillium to Present at the Stifel Virtual Inflammation & Immunology SummitSeptember 10, 2024 | finance.yahoo.comEquillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor ConferenceAugust 28, 2024 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)August 19, 2024 | markets.businessinsider.comEquillium Second Quarter 2024 Earnings: Beats ExpectationsAugust 11, 2024 | finance.yahoo.com Get Equillium News Delivered to You Automatically Sign up to receive the latest news and ratings for EQ and its competitors with MarketBeat's FREE daily newsletter. Email Address EQ Media Mentions By Week EQ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EQ News Sentiment▼0.280.38▲Average Medical News Sentiment EQ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EQ Articles This Week▼61▲EQ Articles Average Week Get Equillium News Delivered to You Automatically Sign up to receive the latest news and ratings for EQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MacroGenics News Today Climb Bio News Today Pliant Therapeutics News Today Anixa Biosciences News Today Oncolytics Biotech News Today Zentalis Pharmaceuticals News Today Surrozen News Today Virios Therapeutics News Today Scilex News Today TScan Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EQ) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equillium, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equillium With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
